Genzyme CorporateSearchGenzyme Websites
MPSI Disease Treatment Information for Patients and FamiliesMPSI Disease Treatment Information for Health Care Providers
MPSI
Health Care Professionals
Disease Overview
Genetics and MPS I
Severe and Attenuated
Symptoms & Symptom Management
Disease Progression
The MPS Family of Diseases
Lysosomal Storage Disorders
Diagnosing MPS I
Treatment Options
The MPS I Registry
Resources and Support

Ocular System

General Physical Appearance
Nervous System

Skeletal System

Respiratory System

Auditory System

Cardiovascular System

Ocular System

Gastrointestinal System

Corneal clouding is a feature of all MPS I patients (Image 1) and can be progressive and obstruct vision.

Corneal clouding
Image
1 - Corneal clouding

Courtesy of J.E. Wraith, MD

Open-angle glaucoma, in which the trabecular meshwork is free from encroachment by the base of the iris, is also a common complication.[1][2] The trabecular meshwork is usually engorged with glycosaminoglycans, and the sclera and cornea are thickened, causing shallow anterior chambers.

Retinal degeneration is common and can be assessed by electroretinogram. It results in decreased peripheral vision and night blindness; the exact etiology is unknown. Visual disturbances can progress to blindness from a combination of retinal pigmentary degeneration, optic nerve compression and atrophy and cortical damage.

Wearing brimmed hat or sunglasses can help individuals with corneal clouding. Patients should be routinely tested for glaucoma by assessing intraocular pressure; monitoring of retinal degeneration is also recommended. Corneal grafting may be helpful for some patients. However, patients with clear grafts may still have poor vision because of associated retinal and/or optic nerve disease.[2][3]

Next: Gastrointestinal System

References:

1. Clarke, L.A. (1997) Clinical diagnosis of lysosomal storage diseases. In: Organelle Diseases. Clinical Features, Diagnosis, Pathogenesis and Management. Applegarth, D.A., Dimmick, J.E., and Hall, J.G. (eds.). Chapman and Hall Medical, London, p. 37.

2. Neufeld, E.F., and Muenzer, J. (2001) The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K.W., and Vogelstein, B. (eds.). 8th edition, Vol. III. McGraw- Hill, Medical Publishing Division, p. 3421.

3. Caruso, R., M. Kaiser-Kupfer, et al (1986). Electroretinographic findings in the mucopolysaccharidoses Ophthalmology 93 (12).

Did you know...
On May 15th, Genzyme and other members of the MPS Community will be recognizing International MPS Awareness Day. Join us in raising awareness of MPS disease disorders and honoring the individuals and families who are affected by it.
Watch Video
Alicia is a 16-year-old with MPS I who was diagnosed 10 years ago. Watch Alicia’s story to find out how she is handling life as a teenager living with MPS I.
Watch the Video
Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142 USA
Phone: 617-768-9000 or
800-745-4447
Contact Genzyme